Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Reviews in medical virology - 1 Jul 2018

Blackard Jason T, Sherman Kenneth E

Abstract excerpt

Hepatitis C virus (HCV) is known to inhibit hepatitis B virus (HBV) replication in patients with HBV/HCV coinfection. Reactivation of HBV in patients treated for HCV with direct-acting agents (DAAs) has emerged recently as an important clinical consideration. A growing number of case reports and case series support the association between new HCV treatments and HBV reactivation. Yet, very little is known about...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Coinfection
Share to Genome, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B virus

Share to Hepatitis C

Share to Microbial Interactions

Share to Virus Activation

Source

Open in PubMed Open full text

Identifiers

PMID: 29761585
DOI: 10.1002/rmv.1984
PMCID: PMC6233878

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).PMID 29761585Read ↗

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infectionSemantic proximity Read ↗

Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.Semantic proximity Read ↗

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.Semantic proximity Read ↗

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.Semantic proximity Read ↗

Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence.Semantic proximity Read ↗

Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNASemantic proximity Read ↗

Mechanism of Hepatitis B Virus cccDNA FormationSemantic proximity Read ↗

Investigational RNA Interference Agents for Hepatitis BSemantic proximity Read ↗

Molecular insights into the mechanisms of occult hepatitis B virus infection.Semantic proximity Read ↗

Chronic HCV Infection Is Associated with Overexpression of Human Endogenous Retroviruses that Persists after Drug-Induced Viral Clearance.Semantic proximity Read ↗

Antiviral Therapy Inhibited HBV-reactivation and Improved Long-term Outcomes in Patients Who Underwent Radiofrequency Ablation for HBV-related Hepatocellular CarcinomaSemantic proximity Read ↗

Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.